β1-Adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction
- 1 October 2009
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 297 (4) , H1377-H1386
- https://doi.org/10.1152/ajpheart.00504.2009
Abstract
The β-adrenergic receptor (βAR) signaling system is one of the most powerful regulators of cardiac function and a key regulator of Ca2+homeostasis. We investigated the role of βAR stimulation in augmenting cardiac function and its role in the activation of Ca2+/calmodulin-dependent kinase II (CaMKII) using various βAR knockouts (KO) including β1ARKO, β2ARKO, and β1/β2AR double-KO (DKO) mice. We employed a murine model of left anterior descending coronary artery ligation to examine the differential contributions of specific βAR subtypes in the activation of CaMKII in vivo in failing myocardium. Cardiac inotropy, chronotropy, and CaMKII activity following short-term isoproterenol stimulation were significantly attenuated in β1ARKO and DKO compared with either the β2ARKO or wild-type (WT) mice, indicating that β1ARs are required for catecholamine-induced increases in contractility and CaMKII activity. Eight weeks after myocardial infarction (MI), β1ARKO and DKO mice showed a significant attenuation in fractional shortening compared with either the β2ARKO or WT mice. CaMKII activity after MI was significantly increased only in the β2ARKO and WT hearts and not in the β1ARKO and DKO hearts. The border zone of the infarct in the β2ARKO and WT hearts demonstrated significantly increased apoptosis by TUNEL staining compared with the β1ARKO and DKO hearts. Taken together, these data show that cardiac function and CaMKII activity are mediated almost exclusively by the β1AR. Moreover, it appears that β1AR signaling is detrimental to cardiac function following MI, possibly through activation of CaMKII.Keywords
This publication has 58 references indexed in Scilit:
- Requirement for Ca2+/calmodulin–dependent kinase II in the transition from pressure overload–induced cardiac hypertrophy to heart failure in miceJournal of Clinical Investigation, 2009
- Knockout of β1‐ and β2‐adrenoceptors attenuates pressure overload‐induced cardiac hypertrophy and fibrosisBritish Journal of Pharmacology, 2008
- β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotectionJournal of Clinical Investigation, 2007
- Propranolol causes a paradoxical enhancement of cardiomyocyte foetal gene response to hypertrophic stimuliBritish Journal of Pharmacology, 2007
- Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivoAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channelsJournal of Clinical Investigation, 2006
- CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophyJournal of Clinical Investigation, 2006
- Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefactionJournal of Clinical Investigation, 2006
- Protecting the myocardium: A role for the β2 adrenergic receptor in the heartCritical Care Medicine, 2004
- Targeting the Receptor-G q Interface to Inhibit in Vivo Pressure Overload Myocardial HypertrophyScience, 1998